Featured Publications
Alcohol Use Disorder and Chronic Pain: An Overlooked Epidemic
De Aquino J, Sloan M, Nunes J, Costa G, Katz J, de Oliveira D, Ra J, Tang V, Petrakis I. Alcohol Use Disorder and Chronic Pain: An Overlooked Epidemic. American Journal Of Psychiatry 2024, 181: 391-402. PMID: 38706339, PMCID: PMC11521207, DOI: 10.1176/appi.ajp.20230886.Peer-Reviewed Original ResearchConceptsAlcohol use disorderChronic painAUD studiesChronic pain disordersChronic pain outcomesRisk of relapseAlcohol withdrawal syndromeAssessment of painHigher levels of alcohol consumptionLevels of alcohol consumptionWithdrawal syndromePain disordersPain outcomesAcute toleranceNeurobiological changesClinical significanceUse disorderPainClinical relevanceSelf-reportAlcohol intoxicationAlcohol consumptionGeneral populationMedical conditionsNarrative reviewThe impact of cannabis on non-medical opioid use among individuals receiving pharmacotherapies for opioid use disorder: a systematic review and meta-analysis of longitudinal studies
Costa G, Nunes J, Heringer D, Anand A, De Aquino J. The impact of cannabis on non-medical opioid use among individuals receiving pharmacotherapies for opioid use disorder: a systematic review and meta-analysis of longitudinal studies. The American Journal Of Drug And Alcohol Abuse 2024, 50: 12-26. PMID: 38225727, DOI: 10.1080/00952990.2023.2287406.Peer-Reviewed Original ResearchConceptsNon-medical opioid useOpioid use disorderOpioid useCannabis useOpioid use disorder pharmacotherapyUse disorderImpact of cannabis useAverage follow-up timeFollow-up timeMeta-analysisEvidence of moderate heterogeneityImpact of cannabisPooled odds ratioOpioids non-medicallyRandom-effects modelMeta-analysis of longitudinal studiesCannabis abstinenceTreatment modalitiesOdds ratioModerate heterogeneityPharmacotherapyCannabisOpioidComprehensive searchPublication biasWhat Would Equitable Harm Reduction Look Like?
Jegede O, Nunes J, Tumenta T, Black C, DeAquino J. What Would Equitable Harm Reduction Look Like? The AMA Journal Of Ethic 2024, 26: e572-579. PMID: 38958426, DOI: 10.1001/amajethics.2024.572.Peer-Reviewed Original ResearchConceptsDeterminants of health frameworkHarm reductionPerson-centered interventionsReduction programsPromote harm reductionHarm reduction strategiesHarm reduction programsHealth equityHealth frameworkEthnic inequalitiesSocial justiceDrug usePWUDOrganizational policiesMargin ExperimentReduction strategiesHarmCareStigmaProgramHealthRaciallyAntiracistInterventionJustice
2023
A Randomized Clinical Trial to Evaluate an Atrial Fibrillation Stroke Prevention Shared Decision‐Making Pathway
Wang P, Lu Y, Mahaffey K, Lin A, Morin D, Sears S, Chung M, Russo A, Lin B, Piccini J, Hills M, Berube C, Pundi K, Baykaner T, Garay G, Lhamo K, Rice E, Pourshams I, Shah R, Newswanger P, DeSutter K, Nunes J, Albert M, Schulman K, Heidenreich P, Bunch T, Sanders L, Turakhia M, Verghese A, Stafford R. A Randomized Clinical Trial to Evaluate an Atrial Fibrillation Stroke Prevention Shared Decision‐Making Pathway. Journal Of The American Heart Association 2023, 12: e028562. PMID: 36342828, PMCID: PMC9973612, DOI: 10.1161/jaha.122.028562.Peer-Reviewed Original ResearchConceptsDecision Conflict ScaleDecision Regret ScaleDecisional conflictUsual careRegret ScaleConflict ScaleMedian scorePatient-centered designHealth communication principlesPatient decisional conflictComparative effectiveness trialAtrial fibrillationDigital decision aidDecision-making pathwaysClinically meaningful reductionsPatient-clinicianEffectiveness trialDecision aidRandomized clinical trialsSecondary outcomesSecondary end pointsCareStudy populationMeaningful reductionsParticipants
2022
The ENHANCE-AF clinical trial to evaluate an atrial fibrillation shared decision-making pathway: Rationale and study design
Baykaner T, Pundi K, Lin B, Lu Y, DeSutter K, Lhamo K, Garay G, Nunes JC, Morin DP, Sears SF, Chung MK, Paasche-Orlow MK, Sanders LM, Bunch TJ, Hills MT, Mahaffey KW, Stafford RS, Wang PJ. The ENHANCE-AF clinical trial to evaluate an atrial fibrillation shared decision-making pathway: Rationale and study design. American Heart Journal 2022, 247: 68-75. PMID: 35092723, DOI: 10.1016/j.ahj.2022.01.013.Peer-Reviewed Original ResearchConceptsAtrial fibrillationClinical trialsTransient ischemic attackDecisional Conflict ScaleWishes of patientsDecision aidAF careAnticoagulation adherenceAnticoagulation useIndex visitIschemic attackMajor bleedingAnticoagulation therapyUsual careSecondary outcomesPrimary outcomePatient satisfactionStroke reductionClinician satisfactionHealth literacyClinicians toolsTreatment planNew decision aidDecision-making experiencesPatients
2021
Underrepresentation of Ethnic and Racial Minorities in Atrial Fibrillation Clinical Trials
Nunes JC, Rice EN, Stafford RS, Lewis EF, Wang PJ. Underrepresentation of Ethnic and Racial Minorities in Atrial Fibrillation Clinical Trials. Circulation Arrhythmia And Electrophysiology 2021, 14: e010452. PMID: 34789014, DOI: 10.1161/circep.121.010452.Peer-Reviewed Original Research